Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
批准号:
430657
负责人:
Falzarano Darryl
金额:
$106.31万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-05-01 至 2021-05-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In December 2019 a novel coronavirus (CoV) was identified as the cause of pneumonia in a cluster of patients in Wuhan, China. This virus is related to severe acute respiratory syndrome (SARS)-CoV and has been named SARS-CoV-2. Since then (in only the last
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
-
批准号:443206
-
项目类别:Operating Grants
-
资助金额:$3.64万
-
财政年份:2021
-
负责人:Falzarano Darryl
-
依托单位:
Formulation optimization and characterization of a novel combination adjuvant for pandemic preparedness
-
批准号:463759
-
项目类别:Operating Grants
-
资助金额:$14.12万
-
财政年份:2021
-
负责人:Falzarano Darryl
-
依托单位:
Animal models for SARS-CoV-2: vaccines and immune enhancement
-
批准号:422763
-
项目类别:Operating Grants
-
资助金额:$72.83万
-
财政年份:2020
-
负责人:Falzarano Darryl
-
依托单位:
Sex as a Biological Variable Supplement - Animal models for SARS-CoV-2: vaccines and immune enhancement
-
批准号:424689
-
项目类别:Operating Grants
-
资助金额:$3.64万
-
财政年份:2020
-
负责人:Falzarano Darryl
-
依托单位:
A ONE Health approach for the prevention of MERS-CoV
-
批准号:368988
-
项目类别:Operating Grants
-
资助金额:$49.49万
-
财政年份:2017
-
负责人:Falzarano Darryl
-
依托单位:
海外基金